Works by Kubo, Takuya


Results: 82
    1
    2

    Thyroid‐stimulating hormone is an independent risk factor of non‐alcoholic fatty liver disease.

    Published in:
    JGH Open, 2020, v. 4, n. 3, p. 400, doi. 10.1002/jgh3.12264
    By:
    • Tahara, Kazuki;
    • Akahane, Takemi;
    • Namisaki, Tadashi;
    • Moriya, Kei;
    • Kawaratani, Hideto;
    • Kaji, Kosuke;
    • Takaya, Hiroaki;
    • Sawada, Yasuhiko;
    • Shimozato, Naotaka;
    • Sato, Shinya;
    • Saikawa, Soichiro;
    • Nakanishi, Keisuke;
    • Kubo, Takuya;
    • Fujinaga, Yukihisa;
    • Furukawa, Masanori;
    • Kitagawa, Koh;
    • Ozutsumi, Takahiro;
    • Tsuji, Yuuki;
    • Kaya, Daisuke;
    • Ogawa, Hiroyuki
    Publication type:
    Article
    3

    A μ-Oxo-μ-η.

    Published in:
    Angewandte Chemie International Edition, 2008, v. 47, n. 52, p. 10195, doi. 10.1002/anie.200804685
    By:
    • Kondo, Shoichi;
    • Saruhashi, Kowichiro;
    • Seki, Kenichi;
    • Matsubara, Koutatsu;
    • Miyaji, Katsuaki;
    • Kubo, Takuya;
    • Matsumoto, Kazuhiro;
    • Katsuki, Tsutomu
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Combined effect of a farnesoid X receptor agonist and dipeptidyl peptidase‐4 inhibitor on hepatic fibrosis.

    Published in:
    Hepatology Research, 2019, v. 49, n. 10, p. 1147, doi. 10.1111/hepr.13385
    By:
    • Shimozato, Naotaka;
    • Namisaki, Tadashi;
    • Kaji, Kosuke;
    • Kitade, Mitsuteru;
    • Okura, Yasushi;
    • Sato, Shinya;
    • Moriya, Kei;
    • Seki, Kenichiro;
    • Kawaratani, Hideto;
    • Takaya, Hiroaki;
    • Sawada, Yasuhiko;
    • Saikawa, Soichiro;
    • Nakanishi, Keisuke;
    • Furukawa, Masanori;
    • Fujinaga, Yukihisa;
    • Kubo, Takuya;
    • Asada, Kiyoshi;
    • Kitagawa, Koh;
    • Tsuji, Yuki;
    • Kaya, Daisuke
    Publication type:
    Article
    14

    Identification of clinical risk factors for histological progression of primary biliary cholangitis.

    Published in:
    Hepatology Research, 2019, v. 49, n. 9, p. 1015, doi. 10.1111/hepr.13355
    By:
    • Fujinaga, Yukihisa;
    • Namisaki, Tadashi;
    • Moriya, Kei;
    • Kitade, Mitsuteru;
    • Kawaratani, Hideto;
    • Shimozato, Naotaka;
    • Kaji, Kosuke;
    • Takaya, Hiroaki;
    • Sawada, Yasuhiko;
    • Seki, Kenichiro;
    • Akahane, Takemi;
    • Okura, Yasushi;
    • Sato, Shinya;
    • Saikawa, Soichiro;
    • Nakanishi, Keisuke;
    • Kubo, Takuya;
    • Furukawa, Masanori;
    • Kitagawa, Koh;
    • Ozutsumi, Takahiro;
    • Tsuji, Yuki
    Publication type:
    Article
    15

    Combining probiotics and an angiotensin‐II type 1 receptor blocker has beneficial effects on hepatic fibrogenesis in a rat model of non‐alcoholic steatohepatitis.

    Published in:
    Hepatology Research, 2019, v. 49, n. 3, p. 284, doi. 10.1111/hepr.13281
    By:
    • Sawada, Yasuhiko;
    • Kawaratani, Hideto;
    • Kubo, Takuya;
    • Fujinaga, Yukihisa;
    • Furukawa, Masanori;
    • Saikawa, Soichiro;
    • Sato, Shinya;
    • Seki, Kenichiro;
    • Takaya, Hiroaki;
    • Okura, Yasushi;
    • Kaji, Kosuke;
    • Shimozato, Naotaka;
    • Mashitani, Tsuyoshi;
    • Kitade, Mitsuteru;
    • Moriya, Kei;
    • Namisaki, Tadashi;
    • Akahane, Takemi;
    • Mitoro, Akira;
    • Yamao, Junichi;
    • Yoshiji, Hitoshi
    Publication type:
    Article
    16

    Proton pump inhibitor therapy does not increase serum endotoxin activity in patients with cirrhosis.

    Published in:
    Hepatology Research, 2019, v. 49, n. 2, p. 232, doi. 10.1111/hepr.13249
    By:
    • Okura, Yasushi;
    • Namisaki, Tadashi;
    • Sato, Shinya;
    • Moriya, Kei;
    • Akahane, Takemi;
    • Kitade, Mitsuteru;
    • Kawaratani, Hideto;
    • Kaji, Kosuke;
    • Takaya, Hiroaki;
    • Sawada, Yasuhiko;
    • Shimozato, Naotaka;
    • Seki, Kenichiro;
    • Saikawa, Soichiro;
    • Nakanishi, Keisuke;
    • Furukawa, Masanori;
    • Fujinaga, Yukihisa;
    • Kubo, Takuya;
    • Kaya, Daisuke;
    • Tsuji, Yuki;
    • Ozutsumi, Takahiro
    Publication type:
    Article
    17
    18

    Combined treatment with dipeptidyl peptidase-4 inhibitor (sitagliptin) and angiotensin-II type 1 receptor blocker (losartan) suppresses progression in a non-diabetic rat model of steatohepatitis.

    Published in:
    Hepatology Research, 2017, v. 47, n. 12, p. 1317, doi. 10.1111/hepr.12860
    By:
    • Okura, Yasushi;
    • Namisaki, Tadashi;
    • Moriya, Kei;
    • Kitade, Mitsuteru;
    • Takeda, Kosuke;
    • Kaji, Kosuke;
    • Noguchi, Ryuichi;
    • Nishimura, Norihisa;
    • Seki, Kenichiro;
    • Kawaratani, Hideto;
    • Takaya, Hiroaki;
    • Sato, Shinya;
    • Sawada, Yasuhiko;
    • Shimozato, Naotaka;
    • Furukawa, Masanori;
    • Nakanishi, Keisuke;
    • Saikawa, Soichiro;
    • Kubo, Takuya;
    • Asada, Kiyoshi;
    • Yoshiji, Hitoshi
    Publication type:
    Article
    19
    20

    Efficacy and tolerability of interferon-free regimen for patients with genotype-1 HCV infection.

    Published in:
    Experimental & Therapeutic Medicine, 2018, v. 16, n. 3, p. 2743, doi. 10.3892/etm.2018.6481
    By:
    • Takeda, Kosuke;
    • Noguchi, Ryuichi;
    • Namisaki, Tadashi;
    • Moriya, Kei;
    • Akahane, Takemi;
    • Kitade, Mitsuteru;
    • Kawaratani, Hideto;
    • Shimozato, Naotaka;
    • Kaji, Kosuke;
    • Takaya, Hiroaki;
    • Sawada, Yasuhiko;
    • Seki, Kenichiro;
    • Fujinaga, Yukihisa;
    • Tsuji, Yuki;
    • Kubo, Takuya;
    • Sato, Shinya;
    • Saikawa, Soichiro;
    • Nakanishi, Keisuke;
    • Furukawa, Masanori;
    • Kitagawa, Koh
    Publication type:
    Article
    21
    22
    23
    24
    25

    Therapeutic strategies for alcoholic liver disease: Focusing on inflammation and fibrosis.

    Published in:
    International Journal of Molecular Medicine, 2017, v. 40, n. 2, p. 263, doi. 10.3892/ijmm.2017.3015
    By:
    • HIDETO KAWARATANI;
    • KEI MORIYA;
    • TADASHI NAMISAKI;
    • MASAKAZU UEJIMA;
    • MITSUTERU KITADE;
    • KOUSUKE TAKEDA;
    • YASUSHI OKURA;
    • KOUSUKE KAJI;
    • HIROAKI TAKAYA;
    • NORIHISA NISHIMURA;
    • SHINYA SATO;
    • YASUHIKO SAWADA;
    • KENICHIRO SEKI;
    • TAKUYA KUBO;
    • AKIRA MITORO;
    • JUNICHI YAMAO;
    • HITOSHI YOSHIJI
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Effect of furosemide on muscle cramps in patients with liver cirrhosis.

    Published in:
    Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 1, p. 76, doi. 10.1111/jgh.14820
    By:
    • Sawada, Yasuhiko;
    • Kawaratani, Hideto;
    • Kubo, Takuya;
    • Fujinaga, Yukihisa;
    • Furukawa, Masanori;
    • Saikawa, Soichiro;
    • Sato, Shinya;
    • Takaya, Hiroaki;
    • Kaji, Kosuke;
    • Shimozato, Naotaka;
    • Moriya, Kei;
    • Namisaki, Tadashi;
    • Akahane, Takemi;
    • Mitoro, Akira;
    • Yoshiji, Hitoshi
    Publication type:
    Article
    48

    Severe Aplastic Anemia following Parvovirus B19-Associated Acute Hepatitis.

    Published in:
    Case Reports in Hepatology, 2017, p. 1, doi. 10.1155/2017/1359486
    By:
    • Furukawa, Masanori;
    • Kaji, Kosuke;
    • Masuda, Hiroyuki;
    • Ozaki, Kuniaki;
    • Asada, Shohei;
    • Koizumi, Aritoshi;
    • Kubo, Takuya;
    • Nishimura, Norihisa;
    • Sawada, Yasuhiko;
    • Takeda, Kosuke;
    • Mashitani, Tsuyoshi;
    • Kubo, Masayuki;
    • Amano, Itsuto;
    • Ootani, Tomoyuki;
    • Ohbayashi, Chiho;
    • Murata, Koji;
    • Ann, Tatsuichi;
    • Mitoro, Akira;
    • Yoshiji, Hitoshi
    Publication type:
    Article
    49

    Liver Abscesses after Peritoneal Venous Shunt.

    Published in:
    Case Reports in Gastroenterology, 2013, v. 7, n. 2, p. 245, doi. 10.1159/000351833
    By:
    • Kawaratani, Hideto;
    • Tsujimoto, Tatsuhiro;
    • Kubo, Takuya;
    • Aihara, Yousuke;
    • Takaya, Toshiaki;
    • Uejima, Masakazu;
    • Moriya, Kei;
    • Noguchi, Ryuichi;
    • Yoshiji, Hitoshi;
    • Fukui, Hiroshi
    Publication type:
    Article
    50